First Time Loading...
L

Lucira Health Inc
NASDAQ:LHDX

Watchlist Manager
Lucira Health Inc
NASDAQ:LHDX
Watchlist
Price: 0.0339 USD -19.29% Market Closed
Updated: May 6, 2024

Lucira Health Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lucira Health Inc
Selling, General & Administrative Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
L
Lucira Health Inc
NASDAQ:LHDX
Selling, General & Administrative
-$35.5m
CAGR 3-Years
-171%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Selling, General & Administrative
-$4.7B
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Boston Scientific Corp
NYSE:BSX
Selling, General & Administrative
-$5.3B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Stryker Corp
NYSE:SYK
Selling, General & Administrative
-$7B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Abbott Laboratories
NYSE:ABT
Selling, General & Administrative
-$11.1B
CAGR 3-Years
-4%
CAGR 5-Years
-3%
CAGR 10-Years
-6%
Intuitive Surgical Inc
NASDAQ:ISRG
Selling, General & Administrative
-$2B
CAGR 3-Years
-17%
CAGR 5-Years
-15%
CAGR 10-Years
-12%

See Also

What is Lucira Health Inc's Selling, General & Administrative?
Selling, General & Administrative
-35.5m USD

Based on the financial report for Dec 31, 2021, Lucira Health Inc's Selling, General & Administrative amounts to -35.5m USD.

What is Lucira Health Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 3Y
-171%

Over the last year, the Selling, General & Administrative growth was -531%. The average annual Selling, General & Administrative growth rates for Lucira Health Inc have been -171% over the past three years .